More reports from the EAU “Update on Prostate Cancer”

Dr. Zachary Klaassen and UroToday have provided us with four more interesting summaries of presentations by faculty at the European Association for Urology (EAU)’s meeting in Vienna last weekend. … READ MORE …

Next prostate cancer CureTalk on January 20

The next CureTalk program on prostate cancer is scheduled for January 20, 2015, at 5:00 p.m. Eastern time in the USA. The featured speaker is Dr. James Mohler of the Roswell Park Cancer Center in Buffalo, New York. To register for this program, … READ MORE …

Improving diagnosis, prognosis, and treatment decision-making

Whatever one’s views on the relative merits of mass screening or carefully targeted, risk-based testing, there is little doubt that we need to do better in deciding who to biopsy once prostate cancer is suspected and who to treat when it is identified. … READ MORE …

Genomics, prostate cancer, and biomarker development

A number of readers may be interested in an article by Yadav et al. in the January issue of AUA News, entitled “Genomics at the forefront of biomarker development for prostate cancer detection and therapeutics.” … READ MORE …

Reports from the annual meeting of the Society for Urologic Oncology

A series of summary reports from the first day of the 14th annual meeting of the Society for Urologic Oncology (SUO) has recently been made available on the UroToday web site (which is freely accessible to patients, but you do have to register to access it). … READ MORE …

Prostate cancer news reports: Sunday, January 17, 2010

In today’s news reports we address recent publications on:

  • The GEMCaP biomarkers and prediction of prostate cancer recurrence post-surgery
  • Biopsy Gleason score under-staging and active surveillance
  • The value of exercise during radiotherapy
  • Impact of type of surgery on post-surgical continence at 1 year … READ MORE …

New review of biomarkers for prostate cancer detection

Nogueira et al. have just published a new “mini-review” in BJU International that addresses the potential roles of current and “future” biomarkers that may have relevance to prostate cancer detection. … READ MORE …

Prostate cancer news reports: Friday, June 5, 2009

Today’s news reports refer to a series of reviews that appeared this month in a supplement to Urology as well as other articles:

  • 20 years of experience with the PSA test in assessment of risk for prostate cancer
  • Biomarkers in the assessment of future risk for prostate cancer
  • Treatment choice, outcome, and quality of life
  • Using PSA to assess overall survival in CRPC
  • Prognosis of death in hormonally treatment men with metastatic prostate cancer … READ MORE …

The clinical relevance of new biomarkers is tricky

Assiduous readers of this blog will have noted that there are relatively frequent mentions of “new” biomarkers that may have potential as indicators of the aggressiveness of prostate cancer — but that in most cases those biomarkers are never heard of again. … READ MORE …

The prostate cancer news report: Tuesday, May 5, 2009

We are returning to “normal” today with the standard “news reports.” Today’s items deal with:

  • Evolving biomarkers and new tests and their future application
  • MRI in diagnosis, staging, and prognosis of prostate cancer
  • Intraprostatic injection of LHRH agonists and antagonists: is it viable?
  • Gefitinib in HRPC: no evident impact on quality of life … READ MORE …

The Friday news reports (Part B): February 13, 2009

The second set of reports in today’s news commentaries encompasses new nomograms, possible new biomarkers, a specific subtype of prostate cancer, and the “hedgehog” signaling pathway. … READ MORE …

The weekend prostate cancer news: October 25, 2008

Some interesting new reports today include:

  • An update on the Prostate Cancer Prevention Trial
  • Early data on the potential of a traditional Chinese herbal medication
  • Predictive value of PSA velocity in management of low-risk patients with low-dose brachytherapy
  • Reviews of emerging biomarkers and the role(s) of MRI … READ MORE …

Prostate cancer reports from ASTRO, no. 2

Prostate cancer reports from the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), being held in Boston, are kindly provided by Eyad Abu-Isa, MD, a resident in radiation oncology at the University of Michigan.

Most of the prostate cancer data presented in today’s scientific sessions were from retrospective reviews and the afternoon genitourinary session was focused on biomarkers and predictors of outcome in prostate cancer. … READ MORE …